Dong-A ST Co., Ltd.: all 122 studies

Page 1 of 2. Open to participants first (9), then studies with results posted, then the rest; newest registration first within each.

• A Study to Evaluate the Efficacy and Safety of DA-9701 in Patients With Functional DyspepsiaRecruitingNCT07686679Phase 4
• A First-In-Human Phase I/IIa Study to Evaluate DA 3501 in Patients With Advanced Gastric or Gastro-esophageal Junction Adenocarcinoma and Pancreatic Ductal AdenocarcinomaRecruitingNCT07481357Phase 1
• Clinical Trial to Evaluate the Efficacy and Safety of DA-2811 When Added to Ongoing BT-1 and BT-2 Combination Therapy in Patients With Type 2 Diabetes Who Have Inadequate Glycemic ControlNot yet recruitingNCT07239440Phase 2
• Clinical Trial to Evaluate the Efficacy and Safety of DA-5218 in Patients With Type 2 DiabetesNot yet recruitingNCT07229534Phase 4
• Clinical Trial of Comparing DA-5222 Single-administration and Co-administration of DA-5222-R1, DA-5222-R2 and DA-5222-R3 in Healthy Adult SubjectsNot yet recruitingNCT06993181Phase 1
• To Evaluate Effect of Food of DA-5222 in Healthy Adult SubjectsNot yet recruitingNCT06993168Phase 1
• Pharmacokinetics and Safety Profiles After Administration of DA-5221_01 and Co-administration of 5221_01-R1 and DA-5221_01-R2 in Healthy Adult VolunteersNot yet recruitingNCT06616883Phase 1
• Clinical Trial to Investigate Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of DA-4505 as a Single Agent and in Combination With Pembrolizumab in Adult Patients With Locally Advanced or Metastatic Solid TumorsRecruitingNCT06293651Phase 1/2
• Long-term Safety and Effectiveness of Growtropin®-II Treatment in Children With Short StatureRecruitingNCT04798690
• Efficacy, Safety, and Immunogenicity of Subcutaneous DMB-3115 Versus Stelara® in Patients With Moderate to Severe Chronic Plaque PsoriasisCompletedNCT04785326Phase 3Results posted
• Safety and Efficacy of DA-9805 for Parkinson's DiseaseCompletedNCT03189563Phase 2Results posted
• Efficacy and Safety of DA-3002 in Children With Idiopathic Short StatureCompletedNCT01786902Phase 3Results posted
• A Study to Exploratively Evaluate the Safety, Tolerability and Pharmacokinetics of DA-5223 Compared With DA-5223-R in Healthy Adult SubjectsCompletedNCT07633691Phase 1
• A Study to Evaluate the Bioequivalence of DA-5230 Compared to DA-5230-RCompletedNCT07513649Phase 1
• Pharmacokinetics and Safety Profiles of DA-1229_01 in Healthy Subjects at Fed StateCompletedNCT07342062Phase 1
• Pharmacokinetics and Safety Profiles of DA-1229_01 in Healthy Subjects at Fasting StateCompletedNCT07297940Phase 1
• Clinical Trial of Comparing DA-2902 and DA-2902-R in Healthy Adult SubjectsCompletedNCT07239453Phase 1
• A Study to Evaluate the Safety and Efficacy of DA9601 for Acute and Chronic Gastritis and to Determine the Optimal Clinical Dosage and AdministrationCompletedNCT07139886Phase 2
• Clinical Trial Comparing Single-administration of DA-5222 and Co-administration of DA-5222-R1, DA-5222-R2 and DA-5222-R3 in Healthy Adult Subjects in Fed StateCompletedNCT07046715Phase 1
• A Study to Evaluate the Pharmacokinetics and Safety of Diluted vs. Undiluted Intravenous DA-5217 in Healthy Adult SubjectsCompletedNCT07027982Phase 1
• A Study to Compare and Evaluate the Safety, Tolerability and Pharmacokinetics Between DA-5223 and DA-5223-R in Healthy Adult SubjectsCompletedNCT07007533Phase 1
• A Study to Evaluate the Food Effect on the Pharmacokinetics of DA-5223 in Healthy Adult SubjectsWithdrawnNCT07007520Phase 1
• The Effectiveness and Safety of Dong-A Opalmon® Tablet in Patients With Acquired Lumbar Spinal StenosisCompletedNCT06654856
• A Study to Evaluate Safety, Tolerability, and PK of DA-7503 in Healthy Adult and Elderly ParticipantsCompletedNCT06391827Phase 1
• Efficacy and Safety of DA5221-T When Added to Ongoing DA5221-B1 and DA5221-B2 Combination Therapy in Patients With Type 2 Diabetes Who Have Inadequate Glycemic ControlActive, not recruitingNCT06290349Phase 3
• Clinical Trial to Evaluate the Efficacy and Safety of DA-5219 in Patients With Acute or Chronic GastritisCompletedNCT06151210Phase 3
• Drug Interactions When DA-8010 is Co-administered With Paroxetine or Mirabegron in Healthy AdultsCompletedNCT05992428Phase 1
• Evaluate the Effect of Clarithromycin/Rifampicin on the Pharmacokinetics of DA-8010 in Healthy AdultsCompletedNCT05991401Phase 1
• Clinical Study to Evaluate the Efficacy and Safety of DA-2803 in Chronic Hepatitis B PatientsCompletedNCT05957380Phase 4
• Clinical Trial of DA-5212 in Patients with Functional DyspepsiaCompletedNCT05842408Phase 3
• A Study to Evaluate the Effects of Renal Function on Pharmacokinetics and Safety of DA-8010CompletedNCT05812417Phase 1
• Clinical Trial to Evaluate the Efficacy and Safety of DA-2811 When Added to Ongoing Metformin Monotherapy in Patients with Type 2 Diabetes Who Have Inadequate Glycemic ControlCompletedNCT05743907Phase 4
• Phamacokinetics and Safety Profiles of DA-1229_01 5/1000mg in Healthy Subjects at Fed StateStatus unknownNCT05739916Phase 1
• Phamacokinetics and Safety Profiles of DA-1229_01 5/1000mg in Healthy Subjects at Fasting StateStatus unknownNCT05739903Phase 1
• Phamacokinetics and Safety Profiles of DA-1229_01 2.5/500mg in Healthy Subjects at Fed StateStatus unknownNCT05739877Phase 1
• Phamacokinetics and Safety Profiles of DA-1229_01 2.5/500mg in Healthy Subjects at Fasting StateStatus unknownNCT05739851Phase 1
• Efficacy and Safety of Actonel® After Denosumab Discontinuation in Postmenopausal Osteoporosis WomenCompletedNCT05630768Phase 4
• A Clinical Trial to Compare the Safety, Tolerability, and PK Properties of DA-5216 and DA-5216-R and to Evaluate the Food Effect on DA-5216.Status unknownNCT05506007Phase 1
• Pharmacokinetics and Safety Profiles After Administration of DA-5218 and Co-administration of DA-5218-R1, DA-5218-R2 and DA-5218-R3 in Healthy Adult VolunteersStatus unknownNCT05449704Phase 1
• Bioequivalence Study Between "DA-5215 Tab" and "DA-5215-R Tab"Status unknownNCT05376085Phase 1
• A Study to Evaluate the Efficacy and Safety of DA-8010 in Patients With Overactive BladderCompletedNCT05282069Phase 3
• Pharmacokinetics and Safety Profiles After Administration of DA-5211 and Co-administration of DA-5211-R1 and DA-5211-R2 in Healthy Adult VolunteersCompletedNCT05132049Phase 1
• Phase 1 Clinical Trial of DA-5207 in Healthy AdultsCompletedNCT05127746Phase 1
• Phamacokinetics and Safety Profiles of DA-5210 10/1000mg in Healthy Subjects at Fasting StateCompletedNCT05108571Phase 1
• Phamacokinetics and Safety Profiles of DA-5213 10mg in Healthy SubjectsCompletedNCT05106205Phase 1
• Phamacokinetics and Safety Profiles of DA-5210 10/1000mg in Healthy Subjects at Fed StateCompletedNCT05098886Phase 1
• Phamacokinetics and Safety Profiles of DA-5210 10/500mg in Healthy Subjects at Fed StateCompletedNCT05098275Phase 1
• Phamacokinetics and Safety Profiles of DA-5210 10/500mg in Healthy Subjects at Fasting StateCompletedNCT05098262Phase 1
• Pharmacokinetics and Safety/Tolerability Profiles of DA-2811 in Healthy Subjects (DA-2811)CompletedNCT04938752Phase 1
• Clinical Study to Evaluate the Pharmacokinetics, Safety and Tolerability of DA-2803 in Healthy SubjectsCompletedNCT04906109Phase 1
• The Food Effect on Pharmacokinetics of DA-8010 After a Single Administration of DA-8010 2.5 mg or 5 mg in Healthy SubjectsCompletedNCT04686825Phase 1
• Bioequivalence Study Between "DA-5209 Tab" and "Lixiana Tab"CompletedNCT04671316Phase 1
• A Clinical Trial to Evaluate the Preference Regarding Convenience of Medication and Efficacy/Safety of SUGAMET®XR Tablet 5/1000mgStatus unknownNCT04653779Phase 4
• Phase 1 Clinical Trial to Evaluate the Safety, PK and PD of DA-5207 TDS in Healthy AdultsStatus unknownNCT04479865Phase 1
• Pharmacokinetics and Safety/Tolerability Profiles of DA-2811 in Healthy SubjectsCompletedNCT04473417Phase 1
• Efficacy and Safety of Dapagliflozin When Added to Ongoing Metformin and Evogliptin Combination Therapy in Patients With Type 2 Diabetes Who Have Inadequate Glycemic ControlCompletedNCT04356742Phase 3
• Observational Study to Evaluate the Efficacy and Safety of Suganon Tab. or Sugamet XR Tab.Status unknownNCT04326166
• Bioequivalence Study Between "Dong-A Atorvastatin Tab" and "Lipitor Tab"Status unknownNCT04325009Phase 1
• The Pharmacokinetics/Pharmacodynamics and Safety/Tolerability of Evogliptin in Hemodialysis PatientsCompletedNCT04195919Phase 1
• Efficacy and Safety of Evogliptin When Added to Ongoing Metformin and Dapagliflozin Combination Therapy in Patients With Type 2 Diabetes Who Have Inadequate Glycemic ControlCompletedNCT04170998Phase 3
• BE Study of Gaster®D Tab 20mg (Manufacturer Changed)Status unknownNCT04123899Not applicable
• Clinical Study to Evaluate Efficacy and Safety of DA-1229 in Patients With CAVDCompletedNCT04055883Phase 2
• Single-ascending Dose Phase 1 Clinical Trial to Evaluate the Safety and PK of DA-5207 TDS in Healthy AdultsCompletedNCT04013477Phase 1
• A Study to Investigate the Bioequivalence Test of DA-1229_01(A) at Fed StateCompletedNCT03944200Phase 1
• A Study to Investigate the Bioequivalence Test of DA-1229_01(A) at Fasting StateCompletedNCT03939143Phase 1
• Bioequivalence Test of "Dong-a Bepotastine Besilate Tab" and "Twolion Tab"CompletedNCT03932435Not applicable
• Efficacy and Safety of Evoglitin in Patients With Type 2 Diabetes and Non-alcoholic Fatty Liver DiseasesCompletedNCT03910361Phase 4
• Pharmacokinetic and Pharmacodynamic Drug-Drug Interaction of Evogliptin and Empagliflozin or Dapagliflozin in Healthy Male AdultsCompletedNCT03766724Phase 1
• A Study to Evaluate the Safety, Tolerability, PK and PD of DA-1241 in Healthy Male Subjects and Subjects With T2DMCompletedNCT03646721Phase 1
• A Therapeutic Exploratory Clinical Study of DA-8010 in Patients With Overactive BladderCompletedNCT03566134Phase 2
• To Evaluate the Efficacy, Safety, and Immunogenicity of Subcutaneous Eporon Versus Epoetin Alfa (Eprex)Status unknownNCT03521713Phase 3
• A Study to Evaluate the Efficacy, Safety and Immunogenicity of Leucostim® Versus Neupogen® in Breast Cancer PatientsCompletedNCT03343145Phase 3
• Phase IV Clinical Trial to Evaluate the Efficacy and Safety of Jublia® in Mild to Moderate Toenail OnychomycosisCompletedNCT03280927Phase 4
• Pharmacokinetics and Safety/Tolerability Profiles of DA-5206 Versus Talion® Under Fasting and Fed States in Healthy Male SubjectsCompletedNCT03200496Phase 1
• A Study To Evaluate The Safety,Tolerability, PK and PD Of DA-1241 In Healthy Male SubjectsCompletedNCT03061981Phase 1
• Phase IV Clinical Trial to Investigate the Effect on Blood Glucose of Evogliptin in Patients With Type 2 Diabetes(EVERGREEN)CompletedNCT02974504Phase 4
• Efficacy and Safety of DA-2802 in Chronic Hepatitis B PatientsCompletedNCT02967939Phase 3
• A Study to Evaluate Safety, Tolerability, and Pharmacokinetics/Pharmacodynamics of Tripegfilgrastim in Pediatric Solid Tumor/Lymphoma PatientsCompletedNCT02963389Phase 1
• Assessment the Efficacy of Acetyl-L-carnitine in Patient With Alzheimer's DiseaseCompletedNCT02955706Phase 4
• Pharmacokinetic/Pharmacodynamic Drug-drug Interaction of Evogliptin 5mg and Glimepiride 4mgCompletedNCT02954822Phase 1
• Efficacy and Safety of Evogliptin add-on to Metformin in Patients With type2 DiabetesCompletedNCT02949193Phase 3
• A Clinical Trial to Investigate the Efficacy and Safety of EvogliptinCompletedNCT02946541Phase 3
• Pharmacokinetics/ Pharmacodynamics and Safety of DA-4001 in Healthy Male Subjects With Androgenic AlopeciaCompletedNCT02824380Phase 1
• A Study to Evaluate Safety, Tolerability and Pharmacokinetics of DA-8010 in Healthy SubjectsStatus unknownNCT02821312Phase 1
• Study to Compare the Efficacy and Safety of CELBESTA® and CELEBREX® in Patients With Rheumatoid ArthritisCompletedNCT02780323Phase 4
• Efficacy and Safety of DA-3002 in Short Children Borns SGA.CompletedNCT02770157Phase 3
• Pharmacokinetics and Safety of Evogliptin in Subjects With Hepatic DysfunctionCompletedNCT02754219Phase 1
• Pharmacokinetic/Pharmacodynamic Drug-drug Interaction of Evogliptin 5 mg and Pioglitazone 30 mgCompletedNCT02753803Phase 1
• Evaluation of Pharmacokinetic/Pharmacodynamic Properties and Safety of Leucostim® Compared to Neupogen® in Healthy Adult VolunteersCompletedNCT02725086Phase 1
• To Investigate the Pharmacokinetics of EPORON® and EPREX® After Subcutaneous Administration in Healthy Male VolunteersStatus unknownNCT02580006Phase 1
• Clinical Trial to Assess the Safety and Pharmacokinetics of DA-2802 319mg and Viread 300mg in Healthy Male VolunteersCompletedNCT02557594Phase 1
• Study to Evaluate the Efficacy and Safety of Intra-articular DA-5202 in Patients With Osteoarthritis of the KneeCompletedNCT02554240Phase 2
• The Efficacy and Safety of OROSARTAN® Versus CODIOVAN® in Patients With Essential Hypertension Uncontrolled With MonotherapyCompletedNCT02433119Phase 4
• A Clinical Trial to Investigate Safety/Tolerability and Pharmacokinetics of DA-1229_01(Evogliptin/Metformin XR 2.5/500 mg x 2 Tablets) Compared to Co-administration of Evogliptin 5 mg and Metformin XR 1000 mg in Healthy Male VolunteersCompletedNCT02375139Phase 1
• Study of Motilitone to Treat Functional DyspepsiaCompletedNCT02365701Phase 2
• Clinical Trial to Evaluate the Long-term Safety of Udenafil in Patient With PAHCompletedNCT02304198Phase 2/3
• A Study to Evaluate the Efficacy and Safety of DA-5204Status unknownNCT02282670Phase 3
• Clinical Trial to Explore the Efficacy and Safety of DA-4001 After Topical ApplicationCompletedNCT02280603Phase 1/2
• Comparison of the Efficacy and Safety of Cresnon® and Crestor® in Patients With HyperlipidemiaCompletedNCT02280590Phase 4
• Microtracer Study to Establish Absolute Bioavailability and the Absorption, Metabolism, Excretion of DA-1229Status unknownNCT02267902Phase 1

← Dong-A ST Co., Ltd. overview and focus areas